YSM Logo
 Hodsdon Laboratory -- Publications YSM Logo

  1. Hodsdon, M.E., Toner, J.J. and Cistola, D.P. (1994) Sequence-Specific 1H, 13C, and 15N Resonance Assignments for Intestinal Fatty Acid-Binding Protein Complexed with Palmitate (15.4 kDa).  In Proceedings of Stable Isotope Applications in Biomolecular Structure and Mechanisms, Los Alamos National Laboratory, New Mexico, p. 340.
  2. Hodsdon, M.E., Toner, J.J. and Cistola, D.P. (1995) 1H, 13C, and 15N Assignments and Chemical Shift-Derived Secondary Structure of Intestinal Fatty Acid-Binding Protein. J. Biomol. NMR 6, 198-210.
  3. Hodsdon, M.E., Ponder, J.W. and Cistola, D.P. (1996) The NMR Solution Structure of Intestinal Fatty Acid-Binding Protein Complexed with Palmitate: Application of a Novel Distance Geometry Algorithm. J. Mol. Biol. 264, 585-602.  Full Text
  4. Hodsdon, M.E. and Cistola, D.P. (1997) Discrete Backbone Disorder in the Nuclear Magnetic Resonance Structure of Apo Intestinal Fatty Acid-Binding Protein: Implications for the Mechanism of Ligand Entry. Biochemistry 36, 1450-1460. Full Text
  5. Hodsdon, M.E. and Cistola, D.P. (1997) Ligand Binding Alters the Backbone Mobility of Intestinal Fatty Acid-Binding Protein as Monitored by 15N NMR Relaxation. Biochemistry 36, 2278-2290.  Full Text
  6. Steele, R.A., Emmert, D.A.,  Kao J., Hodsdon, M.E., Frieden, C. and Cistola, D.P., (1997) The Solution Structure of a Helix-less Variant of Intestinal Fatty Acid-Binding Protein. Protein Science 7, 1332-1339.
  7. Hodsdon, M.E. and Frieden, C. (2001) The Intestinal Fatty Acid-Binding Protein: The Folding Mechanism as Determined by NMR Studies. Biochemistry 40, 732-742.  Full Text
  8. Sankoorikal, B.J., Zhu, Y.L., Hodsdon, M.E., Lolis, E. and Dannies, P.S. (2001) Aggregation of human wild-type and H27A-prolactin in solution and in cells: roles of Zn2+, Cu2+, and pH. Endocrinology 143, 1302-1309.  Full Text
  9. Keeler, C., Dannies, P.S. and Hodsdon, M.E. (2003) The tertiary structure and backbone dynamics of human prolactin. J. Mol. Biol. 328(5), 1105-1121.  Full Text
  10. Scheuermann, T.H., Lolis, E. and Hodsdon, M.E. (2003) Tertiary structure of thiopurine methyltransferase from Pseudomonas syringae, the bacterial orthologue of a polymorphic, drug-metabolizing enzyme. J. Mol. Biol. 333(3) 573-585.  Full Text
  11. Keeler, C., Hodsdon, M.E., Dannies, P.S. (2003) Is there structural specificity in the reversible protein aggregates stored in secretory granules? J. Mol. Neuroscience 22(1-2), 43 – 50.  Full Text
  12. Devine, L., Hodsdon, M.E., Rogozinski, L, Soundararajan, U., Daniels, M.A., Jameson, S.C. and Kavathas, P.B. (2003) Location of the epitope for an anti-CD8alpha antibody 53.6.7 which enhances CD8alpha-MHC class I interaction inicates that enhancement involves stabilization of a specific CD8 conformation. Immunology Letters 93(2-3), 123-130.
  13. Kritzer, J.A., Hodsdon, M.E., Lear, J.D., Schepartz, A. (2004) Specific recognition of hDM2 by a rationally designed beta-peptide. J. Amer. Chem. Soc.126(31), 9468 – 9469.  Full Text
  14. Scheuermann, T.H., Keeler, C. and Hodsdon, M.E., (2004) Consequences of binding an S-adenosyl-methionine analogue on the structure and dynamics of the thiopurine methyltransferase protein backbone. Biochemistry 43(38), 12198 – 12209.  Full Text
  15. Kritzer, J.A., Hodsdon, M.E. and Schepartz, A. (2005) Solution structure of a b-peptide ligand for hDM2. J. Amer. Chem. Soc. 127(12), 4118 – 4119.
  16. Hsiao AL, Santucci KA, Seo-Meyer P, Mariappan MR, Hodsdon ME, Banasiak KJ, Baum CR. (2005) Pediatric fatality following ingestion of dinitrophenol: post-mortem identification of a “dietary supplement”. J. Toxicol. Clin. Toxicol. 43(4), 281 – 285.
  17. Mao, Y., Semic-Matuglia, F., DiFiore, P.P., Polo, S., Hodsdon,  M.E.* and De Camilli, P.* (2005) De-ubiquitinating function of ataxin-3: insights from the solution structure of the Josephin domain. Proc. Natl. Acad. Sci. U.S.A. 102(36), 12700 – 12705. *co-corresponding authors
  18. Stephens, O.M., Kim, S., Welch, B.D., Hodsdon, M.E., Kay, M.S. and Schepartz, A. (2005) Inhibiting HIV fusion with a b-peptide foldamer. J. Amer. Chem. Soc. 127(38), 13126 – 13127.
  19. Guarracino, D.A., Chiang, H.R., Banks, T.N., Lear, J.D., Hodsdon, M.E. and Schepartz, A. (2006) Relationship between salt-bridge identity and 14-helix stability of b3-peptides in aqueous buffer. Organic Letters 8(5), 807 – 810.
  20. Tettamanzi, M.C., Yu, C., Bogan, J.S. and Hodsdon, M.E. (2005) Solution structure and backbone dynamics of an N-terminal ubiquitin-like domain in the GLUT4-tethering protein, TUG. Protein Science 15(3), 498 – 508.
  21. Devine, L., Thakral, D., Nag, S., Dobbins, J., Hodsdon, M.E. and Kavathas, P.B. (2006) Mapping the binding site on CD8b for MHC Class I reveals mutants with enhanced binding. J. Immunol. 177, 3930 – 3938.
  22. Murphy, J.W., Sachpatzidis, A., Cho, Y., Hodsdon, M.E., and Lolis, E. (2006) Structural basis of CXCL12 (Stromal Cell-derived Factor-1α) binding heparin. J. Biol. Chem., accepted pending revision.
  23. Keeler, C., Jablonski, E.M., Albert, Y.B., Taylor, B.D., Myszka, D.G., Clevenger, C.V. and Hodsdon, M.E. (2006) Variation in aqueous pH over a physiologic range alters the structural stability and function of human prolactin., Biochemistry, accepted pending revision.

Note: A poster is available for download summarizing all of our work on psTPMT to date: psTPMT poster (2.7 MB).

Main People  Projects  Protocols  Publications  Diversions  Facilities  Contact  Links